First Time Loading...

Dongwha Pharm Co Ltd
KRX:000020

Watchlist Manager
Dongwha Pharm Co Ltd Logo
Dongwha Pharm Co Ltd
KRX:000020
Watchlist
Price: 8 640 KRW -0.35% Market Closed
Updated: May 10, 2024

Wall Street
Price Targets

Price Targets Summary
Dongwha Pharm Co Ltd

Wall Street analysts forecast Dongwha Pharm Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Dongwha Pharm Co Ltd is 14 280 KRW with a low forecast of 14 140 KRW and a high forecast of 14 700 KRW.

Lowest
Price Target
14 140 KRW
64% Upside
Average
Price Target
14 280 KRW
65% Upside
Highest
Price Target
14 700 KRW
70% Upside
Dongwha Pharm Co Ltd Competitors:
Price Targets
605507
Guobang Pharma Ltd
40% Upside
JUBLPHARMA
Jubilant Pharmova Ltd
13% Upside
300049
Inner Mongolia Furui Medical Science Co Ltd
53% Downside
AQST
Aquestive Therapeutics Inc
183% Upside
300006
Chongqing Lummy Pharmaceutical Co Ltd
259% Upside
VLS
Vita Life Sciences Ltd
59% Downside
4015
Jamjoom Pharmaceuticals Factory Company SJSC
11% Downside
600572
Zhejiang CONBA Pharmaceutical Co Ltd
7% Upside

Revenue
Forecast

Revenue Estimate
Dongwha Pharm Co Ltd

For the last 8 years the compound annual growth rate for Dongwha Pharm Co Ltd's revenue is 6%. The projected CAGR for the next 2 years is 11%.

6%
Past Growth
11%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Dongwha Pharm Co Ltd

For the last 8 years the compound annual growth rate for Dongwha Pharm Co Ltd's operating income is 20%. The projected CAGR for the next 2 years is 55%.

20%
Past Growth
55%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Dongwha Pharm Co Ltd

For the last 8 years the compound annual growth rate for Dongwha Pharm Co Ltd's net income is 22%. The projected CAGR for the next 2 years is 19%.

22%
Past Growth
19%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Dongwha Pharm Co Ltd's stock price target?
Price Target
14 280 KRW

According to Wall Street analysts, the average 1-year price target for Dongwha Pharm Co Ltd is 14 280 KRW with a low forecast of 14 140 KRW and a high forecast of 14 700 KRW.

What is Dongwha Pharm Co Ltd's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Dongwha Pharm Co Ltd's revenue is 6%. The projected CAGR for the next 2 years is 11%.

What is Dongwha Pharm Co Ltd's Operating Income forecast?
Projected CAGR
55%

For the last 8 years the compound annual growth rate for Dongwha Pharm Co Ltd's operating income is 20%. The projected CAGR for the next 2 years is 55%.

What is Dongwha Pharm Co Ltd's Net Income forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Dongwha Pharm Co Ltd's net income is 22%. The projected CAGR for the next 2 years is 19%.